Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | REGN17372 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on REGN17372, a putative bispecific monoclonal antibody targeting GPRC5D and CD28 (Apr 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| REGN17372 | REGN 17372|REGN-17372 | CD28 Antibody 14 | Limited information is currently available on REGN17372, a putative bispecific monoclonal antibody targeting GPRC5D and CD28 (Apr 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|